1. Home
  2. PULM vs GTIM Comparison

PULM vs GTIM Comparison

Compare PULM & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • GTIM
  • Stock Information
  • Founded
  • PULM 2003
  • GTIM 1987
  • Country
  • PULM United States
  • GTIM United States
  • Employees
  • PULM N/A
  • GTIM N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • GTIM Restaurants
  • Sector
  • PULM Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • PULM 18.3M
  • GTIM 17.1M
  • IPO Year
  • PULM N/A
  • GTIM 1990
  • Fundamental
  • Price
  • PULM N/A
  • GTIM $1.64
  • Analyst Decision
  • PULM
  • GTIM
  • Analyst Count
  • PULM 0
  • GTIM 0
  • Target Price
  • PULM N/A
  • GTIM N/A
  • AVG Volume (30 Days)
  • PULM 17.8K
  • GTIM 13.8K
  • Earning Date
  • PULM 11-07-2025
  • GTIM 08-07-2025
  • Dividend Yield
  • PULM N/A
  • GTIM N/A
  • EPS Growth
  • PULM N/A
  • GTIM 17.03
  • EPS
  • PULM N/A
  • GTIM 0.12
  • Revenue
  • PULM $369,000.00
  • GTIM $143,398,000.00
  • Revenue This Year
  • PULM N/A
  • GTIM N/A
  • Revenue Next Year
  • PULM $134.88
  • GTIM N/A
  • P/E Ratio
  • PULM N/A
  • GTIM $13.82
  • Revenue Growth
  • PULM N/A
  • GTIM 1.78
  • 52 Week Low
  • PULM $1.96
  • GTIM $1.34
  • 52 Week High
  • PULM $10.40
  • GTIM $3.00
  • Technical
  • Relative Strength Index (RSI)
  • PULM 47.11
  • GTIM 49.85
  • Support Level
  • PULM $4.45
  • GTIM $1.60
  • Resistance Level
  • PULM $5.50
  • GTIM $1.66
  • Average True Range (ATR)
  • PULM 0.26
  • GTIM 0.04
  • MACD
  • PULM 0.02
  • GTIM 0.00
  • Stochastic Oscillator
  • PULM 38.53
  • GTIM 61.51

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: